Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
Biochemical and Biophysical Research Communications|February 21, 2006
Expression and processing of hepatitis C virus structural proteins in Pichia pastoris yeastGillian Martinez-Donato, Nelson Acosta-Rivero, Juan Morales-Grillo, et al.
Virology Journal|November 28, 2024
Obtaining HBV core protein VLPs carrying SARS-CoV-2 nucleocapsid conserved fragments as vaccine candidatesYadira Lobaina, Alexis Musacchio, Panchao Ai, et al.
Journal of Immunotoxicology|June 10, 2026
Predicting cross reactivity between the fire ant venom allergen Sol i 3 and the antigen 5 from vespid venoms based on molecular modeling computingAmilcar Perez-Riverol, Luis Gustavo Romani Fernandes, José Roberto Aparecido Dos Santos-Pinto, et al.
Archives of Virology|June 23, 2023
Broad humoral immunity generated in mice by a formulation composed of two antigens from the Delta variant of SARS-CoV-2Yadira Lobaina, Rong Chen, Edith Suzarte, et al.
Biochemical and Biophysical Research Communications|November 4, 2004
In vitro assembly into virus-like particles is an intrinsic quality of Pichia pastoris derived HCV core proteinNelson Acosta-Rivero, Armando Rodriguez, Alexis Musacchio, et al.
Biotechnology and Applied Biochemistry|June 3, 2010
Ratio of HCV structural antigens in protein-based vaccine formulations is critical for functional immune response inductionGillian Martínez-Donato, Alexis Musacchio, Liz Alvarez-Lajonchere, et al.
Pageof 5